General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2023-03-13 | 2022-12 | -0.04 | N/A | N/A | N/A |
2022-11-07 | 2022-09 | -0.16 | N/A | N/A | N/A |
2022-08-04 | 2022-06 | -0.27 | N/A | N/A | N/A |
2022-05-05 | 2022-03 | -0.26 | N/A | N/A | N/A |
2022-03-14 | 2021-12 | -0.35 | N/A | N/A | N/A |
2021-11-08 | 2021-09 | -0.36 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2022-11-08 | Stifel | Downgrade | Buy | Hold |
2022-10-31 | JonesTrading | Downgrade | Buy | Hold |
2022-10-24 | SVB Leerink | Downgrade | Outperform | Market Perform |
2022-10-19 | Baird | Downgrade | Outperform | Neutral |
2022-10-18 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
2021-07-12 | HC Wainwright & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-12-19 | BAILEY MICHAEL P | Chief Executive Officer | 340.17K | Conversion of Exercise of derivative security |
2019-04-07 | BARRETT PETER | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Purchase |
2020-06-18 | BASKETT FOREST | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Purchase |
2021-08-09 | FERRARESSO MICHAEL | Officer | 9.24K | Purchase |
2020-06-18 | FLORENCE ANTHONY A JR | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Purchase |
2020-06-18 | GROWTH EQUITY OPPORTUNITIES FUND IV, L.L.C | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-09-29 | NEA Management Company, LLC | 3.95M | 59.29M | 11.37% |
2022-09-29 | AIGH Capital Management LLC | 2.74M | 41.09M | 7.88% |
2022-09-29 | Rubric Capital Management LP | 1.66M | 24.97M | 4.79% |
2022-09-29 | Vanguard Group, Inc. (The) | 1.51M | 22.62M | 4.34% |
2022-09-29 | Worth Venture Partners, Llc | 685.03K | 10.28M | 1.97% |
2022-09-29 | J. Goldman & Co., L.P. | 656.16K | 9.84M | 1.89% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-09-29 | Vanguard Total Stock Market Index Fund | 1.04M | 15.59M | 2.99% |
2022-12-30 | IndexIQ Tr-IQ Merger Arbitrage ETF | 508.82K | 7.63M | 1.46% |
2022-11-29 | Arbitrage Fund | 456.46K | 6.85M | 1.31% |
2022-09-29 | Vanguard Extended Market Index Fund | 412.12K | 6.18M | 1.19% |
2022-11-29 | Fidelity Extended Market Index Fund | 136.35K | 2.05M | 0.39% |
2022-11-29 | AltShares Merger Arbitrage ETF | 135.11K | 2.03M | 0.39% |
Split | Date |
---|---|
1 : 10 | 2020-02-20 |
Next Monday after the close bell is the earning $AVEO
Alex smith sleep for some time HAHAHAHA , OR SELL URS AND SHUT UP $AVEO
This is a 30$ stock $AVEO , hold strong so we screw the bears
Hahahahahaaaaaa $AVEO WHYYYY
The news should’ve been today $AVEO
The news shouldve been todayyyyy $AVEO
I wish we have a buyout $AVEO
Volume after hour is 110000 till now
Next week should b a good for $AVEO
Before or after the bell tomorw the ER $AVRO PLS ?
The buyout article with AstraZeneca was said to be 800 million to 1.2 billion. So we should at least double from here. If not buyout fda cancer drugs typically rise to 1-1.5 billion market cap. So be patient. Up. Soon.
Possible short squeeze later today. All the shorts are jumping on to push down. But possible Pr will flip it. Payments on approval incoming. Market cap I would imagine has to go up to 600 million to billion. Don’t let the market crooks trick you, again. Why do u think patience is most quoted in market? I’m holding for $25-$30. Remember guys drug hits doctors offices in 2-3 weeks.
Sell now